Factors predictive of outcome in patients with de novo status epilepticus

QJM: An International Journal of Medicine

Volumn 102, Issue 1, 2009, Pages 57-62

  Tsai, M H ^a   Chuang, Y C ^a   Chang, H W ^b   Chang, W N ^a   Lai, S L ^a   Huang, C R ^a   Tsai, N W ^a   Wang, H C ^a   Lin, Y J ^a   Lu, C H ^a,c  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

LORAZEPAM; MIDAZOLAM; PHENOBARBITAL; PHENYTOIN; PROPOFOL; VALPROIC ACID;

ADOLESCENT; ADULT; AGED; ARTICLE; CONSCIOUSNESS LEVEL; EPILEPTIC STATE; FEMALE; FOLLOW UP; GLASGOW COMA SCALE; HOSPITAL ADMISSION; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MORTALITY; ONSET AGE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR;

EID: 58149099793     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcn149     Document Type: Article

References (27)

1. Chen JWY, Wasterlain CG. Status epilepticus: Pathophysiology and management in adults. Lancet Neurol 2006; 5:246-56.
2. Garzon E, Fernandes RM, Sakamoto AC. Analysis of clinical characteristics and risk factors for mortality in human status epilepticus. Seizure 2003; 12:337-45.
3. Barry E, Hauser WA. Status epilepticus: The interaction of epilepsy and acute brain disease. Neurology 1993; 43:1473-8.
4. Amare A, Zenebe G, Hammack J, Darvey G. Status epilepticus: Clinical presentation, cause, outcome, and predictors of death in 119 Ethiopian patients. Epilepsia 2008; 49:600-7.
5. Delanty N, French JA, Labar DR, Pedley TA, Rowan AJ. Status epilepticus arising de novo in hospitalized patients: An analysis of 41 patients. Seizure 2001; 10:116-9.
6. ILAE Commission Report. The epidemiology of the epilepsies: Future directions. International League Against Epilepsy. Epilepsia 1997; 38:614-8.
7. Holtkamp M, Othman J, Buchheim K, Meierkord H. Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit. J Neurol Neurosurg Psychiatry 2005; 76:534-9.
8. Meierkord H, Holtkamp M. Non-convulsive status epilepticus in adults: clinical forms and treatment. Lancet Neurol 2007; 6:329-39.
9. Drislane FW. Presentation, Evaluation, and Treatment of Nonconvulsive Status Epilepticus. Epilepsy Behav 2000; 1:301-4.
10. Rossetti AO, Hurwitz S, Logroscino G, Bromfield EB. Prognosis of status epilepticus: Role of aetiology, age, and consciousness impairment at presentation. J Neurol Neurosurg Psychiatry 2006; 77:611-5.
11. Nowak DA, Boehmer R, Fuchs HH. A retrospective clinical, laboratory and outcome analysis in 43 cases of acute aseptic meningitis. Eur J Neurol 2003; 10:271-80.
12. Bottner A, Daneschnejad S, Handrick W, Schuster V, Liebert UG, Kiess W. A season of aseptic meningitis in Germany: Epidemiologic, clinical and diagnostic aspects. Pediatr Infect Dis J 2002; 21:1126-32.
13. Claassen J, Lokin JK, Fitzsimmons BF, Mendelsohn FA, Mayer SA. Predictors of functional disability and mortality after status epilepticus. Neurology 2002; 58:139-42.
14. Vignatelli L, Tonon C, D'Alessandro R. Incidence and shortterm prognosis of status epilepticus in adults in Bologna, Italy. Epilepsia 2003; 44:964-8.
15. Logroscino G, Hesdorffer DC, Cascino GD, Annegers JF, Bagiella E, Hauser WA. Long-term mortality after a first episode of status epilepticus. Neurology 2002; 58:537-41.
16. Logroscino G, Hesdorffer DC, Cascino G, Annegers JF, Hauser WA. Time trends in incidence, mortality, and casefatality after first episode of status epilepticus. Epilepsia 2001; 42:1031-5.
17. Logroscino G, Hesdorffer DC, Cascino G, Annegers JF, Hauser WA. Short-term mortality after a first episode of status epilepticus. Epilepsia 1997; 38:1344-9.
18. DeLorenzo RJ, Pellock JM, Towne AR, Boggs JG. Epidemiology of status epilepticus. J Clin Neurophysiol 1995; 12:316-25.
19. Towne AR, Pellock JM, Ko D, DeLorenzo RJ. Determinants of mortality in status epilepticus. Epilepsia 1994; 35:27-34.
20. Lowenstein DH, Alldredge BK. Status epilepticus at an urban public hospital in the 1980s. Neurology 1993; 43:483-8.
21. Waterhouse EJ, Vaughan JK, Barnes TY, Boggs JG, Towne AR, Kopec-Garnett L, et al. Synergistic effect of status epilepticus and ischemic brain injury on mortality. Epilepsy Res 1998; 29:175-83.
22. Towne AR, Waterhouse EJ, Boggs JG, Garnett LK, Brown AJ, Smith JR, Jr, et al., Prevalence of nonconvulsive status epilepticus in comatose patients. Neurology 2000; 54:340-5.
23. Litt B, Wityk RJ, Hertz SH, Mullen PD, Weiss H, Ryan DD, Henry TR. Nonconvulsive status epilepticus in the critically ill elderly. Epilepsia 1998; 39:1194-202.
24. Lowenstein DH, Aminoff MJ. Clinical and EEG features of status epilepticus in comatose patients. Neurology 1992; 42:100-4.
25. Shneker BF, Fountain NB. Assessment of acute morbidity and mortality in nonconvulsive status epilepticus. Neurology 2003; 61:1066-73.
26. Holtkamp M, Othman J, Buchheim K, Masuhr F, Schielke E, Meierkord H. A "malignant" variant of status epilepticus. Arch Neurol 2005; 62:1428-31.
27. Misra UK, Kalita J, Nair PP. Status epilepticus in central nervous system infections: An experience from a developing country. Am J Med 2008; 121:618-23.